Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

United Therapeutics Corporation (UTHR)

112.72 0.93 (0.83%)

11-13 16:00

Open:

112.78

Pre. Close:

111.79

High:

114.39

Low:

112.03

Volume:

214,060

Market Cap:

4913M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

114.554 - 115.195

115.195 - 115.782

Low:

110.324 - 111.169

111.169 - 111.944

Close:

111.506 - 112.721

112.721 - 113.833

Technical analysis  (as of: 2018-11-13 4:30:40 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 141.79     One year: 150.15

Support:

Support1: 109.82    Support2: 91.37

Resistance:

Resistance1: 121.40    Resistance2: 128.55

Pivot:

115.92

Moving Averages:

MA(5): 114.48     MA(20): 118.07

MA(100): 122.14     MA(250): 121.83

MACD:

MACD(12,26): -2.66     Signal(12,26,9): -2.29

%K %D:

%K(14,3): 19.82     %D(3): 27.25

RSI:

RSI(14): 39.90

52-Week:

High: 152.55  Low: 100.57  Change(%): -6.2

Average Vol(K):

3-Month: 35186  10-Days 45015

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
UTHR has closed above bottom band by 22.3%. Bollinger Bands are 6.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-11-12T11:45:16-05:00
Biotechs getting slammed again, XBI down almost 4%

2018-11-12T06:00:00-05:00
CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

43.59

Shares Float (M)

43.53

% Held by Insiders

0.10

% Held by Institutions

161.00

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

14.030

EPS Est. Current Year

10.600

EPS Est. Next Year

10.970

EPS Est. Next Quarter

2.850

Forward EPS

10.018

Book Value (p.s.)

1.880

PEG Ratio

-0.86

Profit Margin

31.73

Operating Margin

56.60

Return on Assets (ttm)

17.1

Return on Equity (ttm)

22.6

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

628.20

Levered Free Cash Flow (M)

312.15

Valuation

P/E

8.03

P/E Growth Ratio

0.01

P/BV

59.96

P/S

122134352.00

P/CF

7.82

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.